Prostate cancer decisions — 2024

The Veteran's bladder and prostate cancer recurrence is due to the lack of treatment or follow-up after April 2009 TURBT, which may have been caused by VA carelessness. The Board has ordered a remand for further analysis.

The Board denied service connection for kidney cancer and prostate cancer as there was no evidence of herbicide exposure or other link to service.

The Board has determined that the reduction from a 100% to a noncompensable rating for residuals of prostate cancer was proper based on evidence showing no active disease and the Veteran's ability to function under ordinary conditions.

The Board has denied the veteran's claims for compensable disability ratings for Erectile Dysfunction, Prostate Cancer, and Hypertension due to his failure to report for VA examinations without providing good cause.

The Veteran's prostate cancer, linear suprapubic scar, and erectile dysfunction are all granted with effective dates of October 1, 2020.,Special monthly compensation for loss of use of a creative organ is also granted.

The Veteran's prostate cancer is remanded for further review due to conflicting opinions and the need for a comprehensive addendum opinion considering all relevant studies.

The Veteran's service-connected disabilities, including bladder cancer and prostate cancer, have prevented him from securing or following substantially gainful employment since March 22, 2017. A total disability rating based on individual unemployability is granted.

The Veteran's claims for service connection for a bilateral ankle condition, bilateral knee condition, prostate cancer, and hypertension have all been denied as there is no evidence of current disabilities or in-service events that would support these claims.

The Veteran's prostate cancer is remanded for a VA examination to determine if it had onset in, or is otherwise related to, active military service.

The Board has denied the Veteran's claim for a higher rating for prostate cancer and remanded the issue of entitlement to TDIU on an extraschedular basis due to his service-connected disabilities.

The Veteran's service-connected disabilities, including major depression and prostate cancer residuals, prevented him from securing or maintaining substantially gainful employment since January 23, 2012. The Board granted an effective date of January 23, 2012, for TDIU and DEA benefits.

The Board has granted service connection for ischemic heart disease, prostate cancer residuals, and diabetes mellitus due to herbicide exposure. The Veteran's peripheral neuropathy of the bilateral lower extremities is also granted as secondary to his service-connected diabetes mellitus.

The Veteran's prostate cancer residuals, specifically urine leakage, urinary diversion, urinary incontinence, or stress incontinence requiring the wearing of absorbent materials that must be changed 2 to 4 times per day and increased frequency with daytime voiding intervals of less than an hour, are rated at a 40 percent since May 9, 2016.

The appeal to reduce the disability rating for service-connected prostate cancer in remission is dismissed because the proposed reduction was not a final decision.

The Board has granted service connection for the Veteran's residuals of prostate cancer, finding that his current condition is due to his in-service exposure to contaminated water at Camp Lejeune and asbestos.

The Veteran is granted a TDIU from June 9, 2020, due to his service-connected prostate cancer residuals rated at 40 percent. The SMC at the housebound rate is denied prior to September 29, 2020.

The appeal to reduce the Veteran's prostate cancer rating from 100% to 40% is dismissed because it was only a proposal and not a final decision.

The Veteran's claims for service connection for a lumbar spine disability, right hip disability, and prostate cancer have been denied. The Board found that the evidence does not support an in-service injury or disease related to these conditions.,For the lumbar spine and right hip disabilities, the Board determined there was no credible evidence of an in-service injury or disease, and the Veteran's current conditions are not linked to service.

The Veteran's claim for service connection for prostate cancer, including as due to herbicide agent exposure in Thailand, is granted. The effective date of this decision is December 12, 2018.

The Board has decided to remand the case due to insufficient information regarding the Veteran's exposure during service, particularly as a result of his military occupational specialty and service in Korea. The Veteran is seeking service connection for prostate cancer.